Form 13-F position report

MINERVA NEUROSCIENCES INC COM

Reported by STATE STREET CORPORATION

NERV CUSIP 603380106 Manager CIK 0000093751

Reported 0 shares, down 109,762 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 25 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 89000
2022-03-31 91000
2022-06-30 45000
2022-06-30 0
2022-09-30 127000
2022-12-31 21813
2023-03-31 21950
2023-06-30 125392
2023-09-30 113981
2023-12-31 101592
2024-03-31 42619
2024-06-30 52696
2024-09-30 44106
2024-12-31 36672
2025-03-31 28082
2025-06-30 28413
2025-09-30 35020
2025-12-31 96556
2026-03-31 339503
2026-06-30 2358278
2026-09-30 2042612

Quarterly position history

How this manager's reported quarter-end position changed over time.

21 quarters
Quarterly reported position history for MINERVA NEUROSCIENCES INC COM held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 609,735 +184,820 (43.5%) < 0.01% $2,042,612 2026-11-12
Q2 2026 Added 424,915 +368,566 (654.1%) < 0.01% $2,358,278 2026-08-07
Q1 2026 Added 56,349 +32,330 (134.6%) < 0.01% $339,503 2026-05-15
Q4 2025 Added 24,019 +7,500 (45.4%) < 0.01% $96,556 2026-02-13
Q3 2025 Unchanged 16,519 0 (0.0%) < 0.01% $35,020 2025-11-14
Q2 2025 Unchanged 16,519 0 (0.0%) < 0.01% $28,413 2025-08-14
Q1 2025 Unchanged 16,519 0 (0.0%) < 0.01% $28,082 2025-05-15
Q4 2024 Unchanged 16,519 0 (0.0%) < 0.01% $36,672 2025-02-14
Q3 2024 Unchanged 16,519 0 (0.0%) < 0.01% $44,106 2024-11-14
Q2 2024 Unchanged 16,519 0 (0.0%) < 0.01% $52,696 2024-08-14
Q1 2024 Unchanged 16,519 0 (0.0%) < 0.01% $42,619 2024-05-15
Q4 2023 Unchanged 16,519 0 (0.0%) < 0.01% $101,592 2024-02-14
Q3 2023 Added 16,519 +2,800 (20.4%) < 0.01% $113,981 2023-11-14
Q2 2023 Unchanged 13,719 0 (0.0%) < 0.01% $125,392 2023-08-14
Q1 2023 Unchanged 13,719 0 (0.0%) < 0.01% $21,950 2023-05-15
Q4 2022 Unchanged 13,719 0 (0.0%) < 0.01% $21,813 2023-02-14
Q3 2022 Unchanged 13,719 0 (0.0%) < 0.01% $127,000 2022-11-15
Q2 2022 Reduced 0 -109,762 (-100.0%) 0 $0 2022-08-15
Q2 2022 New 13,719 +13,719 (0.0%) < 0.01% $45,000 2022-08-15
Q1 2022 Reduced 109,762 -870 (-0.8%) < 0.01% $91,000 2022-05-16
Q4 2021 Unchanged 110,632 0 (0.0%) < 0.01% $89,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

31 managers reported MINERVA NEUROSCIENCES INC COM for Q2 2022.

Managers reporting MINERVA NEUROSCIENCES INC COM in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Anchor Investment Management LLC Unchanged 12 0 < 0.01% $40 16 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Reduced 0 -129,200 0 $0 8 qtrs
Bank of America Corporation Reduced 0 -144 0 $0 26 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 0 -19,705 0 $0 25 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 16 qtrs
VANGUARD GROUP INC Reduced 0 -3,936,640 0 $0 30 qtrs
ACADIAN ASSET MANAGEMENT LLC Reduced 0 -1,768,685 0 $0 18 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 0 -303,218 0 $0 32 qtrs
Good Life Advisors LLC Reduced 0 -10,000 0 $0 9 qtrs
MORGAN STANLEY Reduced 0 -55,781 0 $0 32 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.